Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -11,283 | -43,310 |
| Depreciation Amortization | 522 | 2,790 |
| Accounts receivable | -1,109 | 0 |
| Accounts payable and accrued liabilities | 463 | 0 |
| Other Working Capital | -1,099 | -1,050 |
| Other Operating Activity | 1,248 | 7,620 |
| Operating Cash Flow | $-11,258 | $-33,950 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -128 | -170 |
| Other Investing Activity | 0 | 1,020 |
| Investing Cash Flow | $-128 | $850 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 13 | 0 |
| Other Financing Activity | 0 | 75,260 |
| Financing Cash Flow | $13 | $75,260 |
| Exchange Rate Effect | 4 | -9 |
| Beginning Cash Position | 45,393 | 3,240 |
| End Cash Position | 34,024 | 45,390 |
| Net Cash Flow | $-11,369 | $42,150 |
| Free Cash Flow | ||
| Operating Cash Flow | -11,258 | -33,950 |
| Capital Expenditure | -128 | 0 |
| Free Cash Flow | -11,386 | -33,950 |